人工智能在预测呼吸道共病毒抑制黄酸的使用
B R P Lopes1, T T Albertini1,2, M F Costa1,3
1Universidade Estadual Paulista - UNESP, Faculdade de Ciências e Letras, Departamento de Ciências Biológicas, Assis, SP, Brasil.
概括
人工智能准确地预测了具有抗人类呼吸道同胞病毒 (hRSV) 活性的黄类药物. 这种方法可能会加速开发新的hRSV治疗方法,减少全球死亡和住院.
科学领域:
- 计算化学是一种计算化学.
- 病毒学 病毒学
- 药物发现 药物发现
背景情况:
- 人类呼吸道同胞性病毒 (hRSV) 导致全球显著的死亡率和发病率.
- 目前对hRSV感染的治疗选择有限,没有可用的疫苗或特定的抗病毒治疗方法.
- 通过传统查方法识别新型抗hRSV化合物是耗时且具有挑战性的.
研究的目的:
- 开发和应用一种人工智能 (AI) 模型,用于预测flavonoids中潜在的抗hRSV活性.
- 为人工智能模型培训利用综合生物,结构和物理化学特性.
- 为了确定有前途的黄类候选人,对hRSV进行进一步的研究.
主要方法:
- 整合各种分子特性 (生物,结构,物理化学) 用于人工智能模型开发.
- 训练和模拟人工智能算法来预测对hRSV的黄类活性.
- 使用命中率和预测准确度评估AI模型性能.
主要成果:
- 开发的AI模型实现了超过83%的预测命中率.
- 人工智能成功地确定了具有抗hRSV活性显著潜力的黄类药物.
- 这些模型证明了区分活性和非活性黄素对hRSV的能力.
结论:
- 人工智能驱动的对黄类抗hRSV活性的预测是一种可行的和有效的策略.
- 鉴定到的黄类化合物需要进一步进行体外和体内药物开发的评估.
- 这种人工智能方法有可能加速发现新型抗RSV疗法,减少疾病负担.
更多相关视频
相关概念视频
Drugs Used in Lower Respiratory Disorders: Overview
509
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
509
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
355
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
355
Common Respiratory Disorders
724
Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
724
Drugs Used in Upper Respiratory Disorders: Overview
300
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
300
Upper Respiratory Drugs: First and Second-Generation Antihistamines
350
Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
350


